Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

NCT00893243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2009-05-05

No results posted yet for this study

Summary

Primary Purpose:

* To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

* Subjective evaluation of symptomatology
* Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Conditions

  • Dry Eye Syndrome

Sponsors & Collaborators

  • Hospital de Sao Sebastiao

    lead OTHER

Principal Investigators

  • Lilianne Duarte, MD · Ophthalmologist

  • José Salgado-Borges, PhD · Ophthalmology Department Director

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893243 on ClinicalTrials.gov